Education
- October 2005: BH in Medicine and Surgery from the University of Bari, Italy.
- July 2011: Master Degree in Geriatric Science at the Geriatric Department - Center for Aging Brain, Memory Unit, University of Bari, Italy.
- 2014: Master in "Systematic Review and Meta-analysis: The Cochrane Collaboration Group" - University of Modena, Italy.
Positions
- 2012: Hired at the ASST "Carlo Poma" in Mantua as permanent medical director at the Emergency Urgency Department (PS / MDU) of the P.O. of Mantua, Italy.
- From May 2014 to May 2016: She took over the management of a post-acute rehabilitation department at the "Golgi Redaelli" Institute in Milan in Abiategrasso, where he consolidated his skills and abilities in managing the main problems related to disability and chronicity.
- Since 1/10/2019: Medical Director at the Scientific Research Institute (Geriatrics Department) Santa Maria Nuova Hospital of Reggio Emilia, Italy.
- Currently in office at the ASST "Carlo Poma of Mantua as medical director in the urgency / emergency department also acting as a geriatrician doctor at the CDCD (Center for dementias and cognitive disorders) of the same hospital in the Department of Neuroscience. As part of this role, she actively collaborates with a multidisciplinary and trans-institutional team to assist patients with cognitive impairment and their families from the first diagnostic approach to the last stages of the disease, using resources to avoid improper access to the emergency / urgency department.
Scientific Competence and Skills
- She has over 15 years of experience on cognitive impairment, in particular on dementias both on a clinical and research level on mental health. The main research areas have developed in the metabolic nutritional field and on the genetic-environmental risk factors of neurodegenerative diseases, with particular focus on the different risk models and their impact on cognitive functions; further areas of interest and management concern the epidemiology of neurodegenerative diseases and the relationship with psycho-emotional aspects of these pathologies.
- In the field of Emergency and Emergency Medicine and Surgery, she has developed management skills from diagnosis to treatment of the main problems related to urgent and emerging geriatric diseases. It also collaborates with excellent results in the management of protected discharge with the social assistance office.
- She has actively participated in several conferences in the context of national and international conferences as a participant but above all as an oral speaker.
- AIP (Italian Association of Psychogeriatrics): Communicative disability, inability to walk and social outcome of hospitalization: experience in the rehabilitation / intermediate care departments of the C. Golgi Institute "(Florence 16-18 April)
- To the European Delirium Association (EDA 2014 6-7 November with oral presentation on: Predictors of recurring delirium among older patients in a rehabilitation setting)
- At the "3rd International Integrated Conference on Psychiatry & Allied Sciences presenting a research work on" Late-life Depression and Alzheimer's Dementia (30-5-2015, Chandigarh India)
- She was invited as a speaker to the "Global forum on dementia" for future research agenda programming with the following talk: "Behavioral and psychological disorders in dementia: the role of Vitamin D. 4-5 September 2018 Venice.
- Parkinson's Disease: New Insights into Pathophysiology and Rehabilitative Approaches. Frisardi V, Santamato A, Cheeran B. Parkinsons Dis. 2016;2016:3121727. doi: 10.1155/2016/3121727. Epub 2016 Jun 30.
- Impact of metabolic syndrome on cognitive decline in older age: protective or harmful, where is the pitfall? Frisardi V. J Alzheimers Dis. 2014;41(1):163-7. doi: 10.3233/JAD-140389.
- Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging. Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Maggi S, Imbimbo BP, Galluzzo L, Baldereschi M, Gandin C, Di Carlo A, Inzitari D, Crepaldi G, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group. Alzheimers Dement. 2013 Mar;9(2):113-22. doi: 10.1016/j.jalz.2011.09.223. Epub 2012 Dec 12.
- Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke. Santamato A, Panza F, Ranieri M, Frisardi V, Micello MF, Filoni S, Fortunato F, Intiso D, Basciani M, Logroscino G, Fiore P. J Neural Transm (Vienna). 2013 Mar;120(3):469-76. doi: 10.1007/s00702-012-0892-x. Epub 2012 Sep 7.
- Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report. Santamato A, Ranieri M, Panza F, Frisardi V, Micello MF, Filoni S, Fiore P. J Rehabil Med. 2012 Sep;44(9):795-7. doi:10.2340/16501977-1009.
- Effectiveness of the frequency rhythmic electrical modulation system for the treatment of chronic and painful venous leg ulcers in older adults. Santamato A, Panza F, Fortunato F, Portincasa A, Frisardi V, Cassatella G, Valente M, Seripa D, Ranieri M, Fiore P. Rejuvenation Res. 2012 . Jun;15(3):281-7. doi: 10.1089/rej.2011.1236. Epub 2012 Jun 7.
- Metabolic-cognitive syndrome: metabolic approach for the management of Alzheimer's disease risk. Frisardi V, Imbimbo BP. J Alzheimers Dis. 2012;30 Suppl 2:S1-4. doi: 10.3233/JAD-2012-120811.
- Apolipoprotein E genotype: the innocent bystander or active bridge between metabolic syndrome and cognitive impairment? Frisardi V. J Alzheimers Dis. 2012;30 Suppl 2:S283-304. doi: 10.3233/JAD-2012-111568. Review.
- Pulmonary rehabilitation for patients with bronchiectasis: case reports. Santamato A, Ranieri M, Panza F, Frisardi V, Marvulli R, Filoni S, Cisari C, Fiore P. Eur J Phys Rehabil Med. 2012 Jun;48(2):293-8. Epub 2012 Apr 17.
- Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A. Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14. Review.
- Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Panza F, Frisardi V, Seripa D, Logroscino G, Santamato A, Imbimbo BP, Scafato E, Pilotto A, Solfrizzi V. Int J Geriatr Psychiatry. 2012 Dec;27(12):1218-38. doi: 10.1002/gps.3772. Epub 2012 Mar 7. Review.
- Calcium channel blockers and Alzheimer's disease: potential relevance in treatment strategies of metabolic syndrome. Goodison WV, Frisardi V, Kehoe PG. J Alzheimers Dis. 2012;30 Suppl 2:S269-82. doi: 10.3233/JAD-2012-111664. Review.
- Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A. Immunotherapy. 2012 Feb;4(2):213-38. doi: 10.2217/imt.11.170. Review.
- Solanezumab for the treatment of mild-to-moderate Alzheimer's disease. Imbimbo BP, Ottonello S, Frisardi V, Solfrizzi V, Greco A, Seripa D, Pilotto A, Panza F. Expert Rev Clin Immunol. 2012 Feb;8(2):135-49. doi: 10.1586/eci.11.93. Review.
- Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group. Age (Dordr). 2013 Apr;35(2):441-53. doi: 10.1007/s11357-011-9360-z. Epub 2011 Dec 28.
- Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation. Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, Greco A, Seripa D, Pilotto A. Curr Med Chem. 2011;18(35):5430-47. Review.
- Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report. Santamato A, Panza F, Di Venere D, Solfrizzi V, Frisardi V, Ranieri M, Fiore P. J Chiropr Med. 2010 Sep;9(3):132-7. doi: 10.1016/j.jcm.2010.04.004.
- Metabolic syndrome as a risk factor for neurological disorders. Farooqui AA, Farooqui T, Panza F, Frisardi V. Cell Mol Life Sci. 2012 Mar;69(5):741-62. doi: 10.1007/s00018-011-0840-1. Epub 2011 Oct 15. Review.
- Metabolic syndrome, cognitive performance, and dementia. Crichton GE, Elias MF, Buckley JD, Murphy KJ, Bryan J, Frisardi V. J Alzheimers Dis. 2012;30 Suppl 2:S77-87. doi: 10.3233/JAD-2011-111022. Review.
- Different models of frailty in predementia and dementia syndromes. Panza F, Solfrizzi V, Frisardi V, Maggi S, Sancarlo D, Adante F, D'Onofrio G, Seripa D, Pilotto A. J Nutr Health Aging. 2011 Aug;15(8):711-9. Review.
- Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Panza F, Frisardi V, Seripa D, D'Onofrio G, Santamato A, Masullo C, Logroscino G, Solfrizzi V, Pilotto A. Ageing Res Rev. 2012 Jan;11(1):87-103. doi: 10.1016/j.arr.2011.06.005. Epub 2011 Jul 7. Review.
- Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA. Prog Lipid Res. 2011 Oct;50(4):313-30. doi: 10.1016/j.plipres.2011.06.001. Epub 2011 Jun 15. Review.
- Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial. Fiore P, Panza F, Cassatella G, Russo A, Frisardi V, Solfrizzi V, Ranieri M, Di Teo L, Santamato A. Eur J Phys Rehabil Med. 2011 Sep;47(3):367-73. Epub 2011 Jun 8.
- Metabolic syndrome, mild cognitive impairment, and dementia. Panza F, Frisardi V, Seripa D, Imbimbo BP, Sancarlo D, D'Onofrio G, Addante F, Paris F, Pilotto A, Solfrizzi V. Curr Alzheimer Res. 2011 Aug;8(5):492-509. Review.
- Mediterranean diet in predementia and dementia syndromes. Solfrizzi V, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, D'Onofrio G, Addante F, Sancarlo D, Cascavilla L, Pilotto A, Panza F. Curr Alzheimer Res. 2011 Aug;8(5):520-42. Review.
- Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab. Panza F, Frisardi V, Imbimbo BP, Seripa D, Paris F, Santamato A, D'Onofrio G, Logroscino G, Pilotto A, Solfrizzi V. Curr Alzheimer Res. 2011 Dec;8(8):808-17. Review.
- Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship. Frisardi V, Panza F, Farooqui AA. Brain Res Rev. 2011 Jun 24;67(1-2):344-55. doi: 10.1016/j.brainresrev.2011.04.003. Epub 2011 Apr 28. Review.
- Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. Panza F, Seripa D, D'Onofrio G, Frisardi V, Solfrizzi V, Mecocci P, Pilotto A. Int J Alzheimers Dis. 2011 Apr 7;2011:721457. doi: 10.4061/2011/721457.
- Diet and Alzheimer's disease risk factors or prevention: the current evidence. Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A. Expert Rev Neurother. 2011 May;11(5):677-708. doi: 10.1586/ern.11.56. Review.
- Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. Solfrizzi V, Scafato E, Frisardi V, Sancarlo D, Seripa D, Logroscino G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F; Italian Longitudinal Study on Aging Working Group. Age (Dordr). 2012 Apr;34(2):507-17. doi: 10.1007/s11357-011 9247-z. Epub 2011 Apr 26.
- Monoclonal antibodies against β-amyloid (Aβ) for the treatment of Alzheimer's disease: the Aβ target at a crossroads. Panza F, Frisardi V, Imbimbo BP, Seripa D, Solfrizzi V, Pilotto A. Expert Opin Biol Ther. 2011 Jun;11(6):679-86. doi: 10.1517/14712598.2011.579099. Epub 2011 Apr 19.
- Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Imbimbo BP, Panza F, Frisardi V, Solfrizzi V, D'Onofrio G, Logroscino G, Seripa D, Pilotto A. Expert Opin Investig Drugs. 2011 Mar;20(3):325-41. doi: 10.1517/13543784.2011.550572. Epub 2011 Jan 11. Review.
- Gerontechnology for demented patients: smart homes for smart aging. Frisardi V, Imbimbo BP. J Alzheimers Dis. 2011;23(1):143-6. doi: 10.3233/JAD-2010-101599.
- Plasma lipid disturbances and cognitive decline. Frisardi V, Panza F, Solfrizzi V, Seripa D, Pilotto A. J Am Geriatr Soc. 2010 Dec;58(12):2429-30. doi: 10.1111/j.1532-5415.2010.03164.x. No abstract available.
- Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease. Panza F, Frisardi V, Imbimbo BP, D'Onofrio G, Pietrarossa G, Seripa D, Pilotto A, Solfrizzi V. Immunotherapy. 2010 Nov;2(6):767-82. doi: 10.2217/imt.10.80. Review.
- Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotyping. Panza F, Frisardi V, Seripa D, Pilotto A, Solfrizzi V. J Am Geriatr Soc. 2010 Nov;58(11):2249-51. doi: 10.1111/j.1532-5415.2010.03110.x. No abstract available.
- Dietary patterns and protection against Alzheimer disease and cognitive decline. Solfrizzi V, Frisardi V, Seripa D, Capurso C, Vendemiale G, Pilotto A, Panza F. Arch Neurol. 2010 Oct;67(10):1285-6; author reply 1287-8. doi: 10.1001/archneurol.2010.244. No abstract available.
- Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report. Santamato A, Panza F, Ranieri M, Amoruso MT, Amoruso L, Frisardi V, Solfrizzi V, Fiore P. J Rehabil Med. 2010 Oct;42(9):891-4. doi: 10.2340/16501977-0596.
- Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, Solfrizzi V. J Alzheimers Dis. 2010;22(3):715-40. doi: 10.3233/JAD-2010-100942.
- Polymorphisms in glutathione S-transferase omega-1 gene and increased risk of sporadic Alzheimer disease. Capurso C, Panza F, Seripa D, Frisardi V, Imbimbo BP, Verdile G, Vendemiale G, Pilotto A, Solfrizzi V. Rejuvenation Res. 2010 Dec;13(6):645-52. doi: 10.1089/rej.2010.1052. Epub 2010 Sep 6.
- Dietary unsaturated fatty acids and risk of mild cognitive impairment. Panza F, Frisardi V, Seripa D, Imbimbo BP, Pilotto A, Solfrizzi V. J Alzheimers Dis. 2010;21(3):867-70. doi: 10.3233/JAD-2010-100777.
- Apolipoprotein E-related all-cause mortality in hospitalized elderly patients. Matera MG, Sancarlo D, Panza F, Gravina C, D'Onofrio G, Frisardi V, Longo G, D'Ambrosio LP, Addante F, Copetti M, Solfrizzi V, Seripa D, Pilotto A. Age (Dordr). 2010 Sep;32(3):411-20. doi: 10.1007/s11357-010-9144-x. Epub 2010 Apr 20.
- Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V. J Alzheimers Dis. 2010;21(3):691-724. doi: 10.3233/JAD-2010-091669. Review.
- Effect of botulinum toxin type A, motor imagery and motor observation on motor function of hemiparetic upper limb after stroke. Santamato A, Panza F, Filoni S, Ranieri M, Solfrizzi V, Frisardi V, Dellomonaco A, Amoruso MT, Amoruso L, Kehoe PG, Megna M, Fiore P. Brain Inj. 2010;24(9):1108-12. doi: 10.3109/02699052.2010.494591.
- Review: γ-Secretase inhibitors for the treatment of Alzheimer's disease: The current state. Panza F, Frisardi V, Imbimbo BP, Capurso C, Logroscino G, Sancarlo D, Seripa D, Vendemiale G, Pilotto A, Solfrizzi V. CNS Neurosci Ther. 2010 Oct;16(5):272-84. doi: 10.1111/j.1755-5949.2010.00164.x. Epub 2010 Jun 16. Review.
- Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F. Ageing Res Rev. 2010 Oct;9(4):399-417. doi: 10.1016/j.arr.2010.04.007. Epub 2010 May 2. Review.
- Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? Frisardi V, Solfrizzi V, Capurso C, Imbimbo BP, Vendemiale G, Seripa D, Pilotto A, Panza F. J Alzheimers Dis. 2010;21(1):57-63. doi: 10.3233/JAD-2010-100015.
- Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. Frisardi V, Solfrizzi V, Capurso C, Kehoe PG, Imbimbo BP, Santamato A, Dellegrazie F, Seripa D, Pilotto A, Capurso A, Panza F. J Alzheimers Dis. 2010;20(1):17-30. doi: 10.3233/JAD-2009-1340. Review.
- Effect of donepezil on the continuum of depressive symptoms, mild cognitive impairment, and progression to dementia. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Chiloiro R, Dellegrazie F, Di Palo A, Capurso A, Solfrizzi V. J Am Geriatr Soc. 2010 Feb;58(2):389-90. doi: 10.1111/j.1532-5415.2009.02702.x. No abstract available.
- Beyond the neurotransmitter-focused approach in treating Alzheimer's disease: drugs targeting beta-amyloid and tau protein. Panza F, Solfrizzi V, Frisardi V, Imbimbo BP, Capurso C, D'Introno A, Colacicco AM, Seripa D, Vendemiale G, Capurso A, Pilotto A. Aging Clin Exp Res. 2009 Dec;21(6):386-406. Review.
- Late-life depression, mild cognitive impairment, and dementia: possible continuum? Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Imbimbo BP, Santamato A, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V. Am J Geriatr Psychiatry. 2010 Feb;18(2):98-116. doi: 10.1097/JGP.0b013e3181b0fa13. Review.
- Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F; Italian Longitudinal Study on Aging Working Group. Neurobiol Aging. 2011 Nov;32(11):1932-41. doi: 10.1016/j.neurobiolaging.2009.12.012. Epub 2009 Dec 31.
- Peripheral antioxidant markers in mild cognitive impairment and its progression to dementia. Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Pilotto A, Frisardi V. J Alzheimers Dis. 2010;21(4):1179-83. Review.
- All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a). Solfrizzi V, Colacicco AM, D'Introno A, Capurso C, Chirico M, Frisardi V, Cacciapaglia M, Vendemiale G, Capurso A, Panza F. Rejuvenation Res. 2009 Dec;12(6):395-402. doi: 10.1089/rej.2009.0865.
- Metabolic syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Ageing. Solfrizzi V, Scafato E, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Vendemiale G, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Capurso A, Panza F; Italian Longitudinal Study on Ageing Working Group. J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):433-40. doi: 10.1136/jnnp.2009.181743. Epub 2009 Dec 3.
- Towards disease-modifying treatment of Alzheimer's disease: drugs targeting beta-amyloid. Frisardi V, Solfrizzi V, Imbimbo PB, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F. Curr Alzheimer Res. 2010 Feb;7(1):40-55. Review.
- Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease. Capurso C, Solfrizzi V, Colacicco AM, D'Introno A, Frisardi V, Imbimbo BP, Lorusso M, Vendemiale G, Denitto M, Santamato A, Seripa D, Pilotto A, Fiore P, Capurso A, Panza F. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):177-82. doi: 10.1016/j.pnpbp.2009.10.022. Epub 2009 Nov 6.
- Botulinum toxin type A in the treatment of painful adductor muscle contracture after total hip arthroplasty. Santamato A, Ranieri M, Panza F, Solfrizzi V, Frisardi V, Lapenna LM, Moretti B, Fiore P. Orthopedics. 2009 Oct;32(10). pii: orthosupersite.com/view.asp?rID=43784. doi: 10.3928/01477447-20090818-29.
- Whole-diet approach: working on a criterion validity for age-related cognitive decline and mild cognitive impairment. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Chiloiro R, Dellegrazie F, Di Palo A, Capurso A, Panza F. J Am Geriatr Soc. 2009 Oct;57(10):1944-6. doi: 10.1111/j.1532-5415.2009.02460.x. No abstract available.
- Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease. Santamato A, Ranieri M, Panza F, Zoccolella S, Frisardi V, Solfrizzi V, Amoruso MT, Amoruso L, Fiore P. J Neurol. 2010 Jan;257(1):139-41. doi: 10.1007/s00415-009-5310-4. No abstract available.
- Dietary fatty acids and predementia syndromes. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Panza F. ScientificWorldJournal. 2009 Aug 11;9:792-810. doi: 10.1100/tsw.2009.82. Review.
- Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Panza F, Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Imbimbo BP. Drugs Aging. 2009;26(7):537-55. doi: 10.2165/11315770-000000000-00000. Review.
- Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Panza F. Ageing Res Rev. 2010 Apr;9(2):184-99. doi: 10.1016/j.arr.2009.07.005. Epub 2009 Jul 28. Review.
- Botulinum toxin type A in the treatment of focal hand dystonia after surgical treatment for thumb duplication. Santamato A, Panza F, Solfrizzi V, Frisardi V, Moretti B, Notarnicola A, Neve A, Ranieri M, Fiore P. Orthopedics. 2009 Jul;32(7):529. doi: 10.3928/01477447-20090527-07.
- Mediterranean dietary pattern, mild cognitive impairment, and progression to dementia. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Panza F. Arch Neurol. 2009 Jul;66(7):912-3; author reply 913-4. doi: 10.1001/archneurol.2009.128. No abstract available.
- Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia. Santamato A, Panza F, Solfrizzi V, Russo A, Frisardi V, Megna M, Ranieri M, Fiore P. J Rehabil Med. 2009 Jul;41(8):639-45. doi: 10.2340/16501977-0384.
- Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Frisardi V, Scapicchio P, Chiloiro R, Scafato E, Gandin C, Vendemiale G, Capurso A, Solfrizzi V. J Alzheimers Dis. 2009;17(4):899-911. doi: 10.3233/JAD-2009-1111.
- Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Lorusso M, Santamato A, Seripa D, Pilotto A, Scafato E, Vendemiale G, Capurso A, Solfrizzi V. J Alzheimers Dis. 2009;17(1):7-31. doi: 10.3233/JAD-2009-1009. Review.
- Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Santamato A, Solfrizzi V, Panza F, Tondi G, Frisardi V, Leggin BG, Ranieri M, Fiore P. Phys Ther. 2009 Jul;89(7):643-52. doi: 10.2522/ptj.20080139. Epub 2009 May 29. Erratum in: Phys Ther. 2009 Sep;89(9):999.
- Possible predictors of vascular cognitive impairment-no dementia. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Seripa D, Pilotto A, Vendemiale G, Capurso A, Solfrizzi V. J Am Geriatr Soc. 2009 May;57(5):943-4. doi: 10.1111/j.1532-5415.2009.02236.x. No abstract available.
- Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Di Palo A, Imbimbo BP, Vendemiale G, Capurso A, Solfrizzi V. ScientificWorldJournal. 2009 May 22;9:373-89. doi: 10.1100/tsw.2009.48. Review.
- Apolipoprotein E, dementia, and human longevity. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Seripa D, Pilotto A, Vendemiale G, Capurso A, Solfrizzi V. J Am Geriatr Soc. 2009 Apr;57(4):740-2. No abstract available.
- Moderate alcohol consumption, apolipoprotein E, and neuroprotection. Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemmiale G, Capurso A, Panza F. Arch Neurol. 2009 Apr;66(4):541-2. doi: 10.1001/archneurol.2009.35. No abstract available.
- Possible role of S-adenosylmethionine, S-adenosylhomocysteine, and polyunsaturated fatty acids in predementia syndromes and Alzheimer's disease. Panza F, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Solfrizzi V. J Alzheimers Dis. 2009;16(3):467-70. doi: 10.3233/JAD-2009-1012.
- Cognitive behavioural group therapy in mild cognitive impairment: intervention with a cognitive or behavioural/psychological focus? Panza F, Frisardi V, Santamato A, Capurso C, D'Introno A, Colacicco AM, Ranieri M, Solfrizzi V. J Rehabil Med. 2009 Mar;41(4):293-4. doi: 10.2340/16501977-0314. No abstract available.
- Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy? Santamato A, Panza F, Solfrizzi V, Frisardi V, Ranieri M, Fiore P. J Rehabil Med. 2008 Nov;40(10):882-3. doi: 10.2340/16501977-0257. No abstract available.
- Role of biphosphonates and lymphatic drainage type Leduc in the complex regional pain syndrome (shoulder-hand syndrome). Santamato A, Ranieri M, Panza F, Solfrizzi V, Frisardi V, Stolfa I, Megna M, Fiore P. Pain Med. 2009 Jan;10(1):179-85. doi: 10.1111/j.1526-4637.2008.00539.
- Mild cognitive impairment: dementia risk factor or high-risk state for progression to dementia? Panza F, Capurso C, D'Introno A, Colacicco AM, Gadaleta A, Frisardi V, Santamato A, Capurso A, Solfrizzi V. J Am Geriatr Soc. 2008 Jul;56(7):1367-9. doi: 10.1111/j.1532-5415.2008.01731.x. No abstract available.
- Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure. Capurso C, Solfrizzi V, D'Introno A, Colacicco AM, Gadaleta A, Frisardi V, Santamato A, Capurso A, Panza F. J Am Geriatr Soc. 2008 Jul;56(7):1366-7. doi: 10.1111/j.1532-5415.2008.01727.
- Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment. Solfrizzi V, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, Ranieri M, Fiore P, Vendemiale G, Seripa D, Pilotto A, Capurso A, Panza F. J Nutr Health Aging. 2008 Jun-Jul;12(6):382-6. Review.
- Vascular risk factors, alcohol intake, and cognitive decline. Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, Ranieri M, Fiore P, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V. J Nutr Health Aging. 2008 Jun-Jul;12(6):376-81.
- Frisardi V . et al. Improving the HealthCare of People with Dementia beyond the Diagnosis: The “Carlo Poma Dementia Care Pathway” Study Protocol . 2019.
